Last update :
08/12/2024
References   References 4818  
Type : Manufacturer

Research teams :
Authors :
Title : Giapreza 2.5mg per ml concentrate for solution for infusion - Summary of Product Characteristics Updated 30-Jun-2022
Reference : PAION UK Ltd 2022

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionAngiotensin II Various
Stability in solutions Not specified Sodium chloride 0,9% 5 >> 10 µg/mL 2-8°C Not specified
24 Hour
Stability in solutions Not specified Sodium chloride 0,9% 5 >> 10 µg/mL 20-25°C Not specified
24 Hour
Compatible + injectionDopamine hydrochloride + Sodium chloride 0,9%
Compatible + injectionEpinephrine hydrochloride + Sodium chloride 0,9%
Compatible + injectionNorepinephrine bitartrate + Sodium chloride 0,9%
Compatible + injectionPhenylephrine hydrochloride + Sodium chloride 0,9%
Compatible + injectionVasopressin + Sodium chloride 0,9%
injectionDopamine hydrochloride Cardiotonic
Compatible + injectionAngiotensin II + Sodium chloride 0,9%
injectionEpinephrine hydrochloride Sympathomimetic
Compatible + injectionAngiotensin II + Sodium chloride 0,9%
injectionNorepinephrine bitartrate Sympathomimetic
Compatible + injectionAngiotensin II + Sodium chloride 0,9%
injectionPhenylephrine hydrochloride Sympathomimetic
Compatible + injectionAngiotensin II + Sodium chloride 0,9%
injectionVasopressin Hormone
Compatible + injectionAngiotensin II + Sodium chloride 0,9%

  Mentions Légales